Mentor and Tutogen form licence agreement:
This article was originally published in Clinica
Executive Summary
Mentor is to distribute Tutogen Medical's Tutoplast processed dermis product on an exclusive basis. The licence calls for minimum purchases of over $1 million in the first year. The product will be used in Mentor's Suspend procedure for the treatment of female incontinence. Tutogen's Tutoplast process of tissue preservation and viral inactivation is used to manufacture bioimplants for neurosurgical, orthopaedic, reconstructive and general surgery applications.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.